# Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site

> **NCT05110781** · PHASE2 · TERMINATED · sponsor: **Arnaud Bewley, MD** · enrollment: 1 (actual)

## Conditions studied

- Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
- Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
- Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8

## Interventions

- **BIOLOGICAL:** Atezolizumab
- **RADIATION:** Radiation Therapy
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT05110781
- **Lead sponsor:** Arnaud Bewley, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-12-07
- **Primary completion:** 2022-05-02
- **Final completion:** 2023-04-18
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2023-09-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05110781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05110781, "Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05110781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*